Increased Formation of Reactive Oxygen Species, but No Changes in Glutathione Peroxidase Activity, in Striata of Mice Transgenic for the Huntington's Disease Mutation

Neurochemical Research

Volumn 29, Issue 4, 2004, Pages 729-733

  Pérez Severiano, Francisca ^a,b   Santamaría, Abel ^a   Pedraza Chaverri, José ^c   Medina Campos, Omar N ^c   Ríos, Camilo ^a   Segovia, José ^b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Catalase; Glutathione peroxidase; Huntington's disease; Oxidative stress; Reactive oxygen species; Striatum; Transgenic R6 1 mice

Indexed keywords

CATALASE; DICHLOROFLUORESCEIN; GLUTATHIONE PEROXIDASE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; AGED; AGING; ANIMAL BEHAVIOR; ANIMAL TISSUE; ARTICLE; CLASPING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; GENE MUTATION; HUNTINGTON CHOREA; MALE; MOUSE; MOUSE STRAIN; MOUSE STRAIN R6 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; WEIGHT REDUCTION;

ANIMALS; CORPUS STRIATUM; GLUTATHIONE PEROXIDASE; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MUTATION; PHENOTYPE; REACTIVE OXYGEN SPECIES;

ANIMALIA; FELIS CATUS; MUS MUSCULUS;

EID: 12144288637     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000018843.83770.4b     Document Type: Article

References (24)

1. Vonsattel, J. P., and DiFiglia, M. 1998. Huntington's disease. J. Neuropathol. Exp. Neurol. 57:369-384.
2. McMurray, C. T. 2001. Huntington's disease: New hope for therapeutics. Trends Neurosci. 24:S32-S38.
3. The Huntington's Disease Collaborative Group. 1993. A novel gene containing trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
4. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., and Bates, G. P. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
5. Usdin, M. T., Shelbourne, P. F., Myers, R. M., and Madison, D. V. 1999. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8:839-846.
6. Beal, M. F. 2000. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23:298-304.
7. Browne, S. E., Bowling, A. C., MacGarvey, U., Baik, M. J., Berger, S. C., Muqit, M. M., Bird, E. D., and Beal, M. F. 1997. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann. Neurol. 41:646-653.
8. Beal, M. F., Brouillet E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J. M., Storey, E., Srivastava, R., Rosen, B. R., and Bradley, T. H. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:4181-4192.
9. Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M., and Schapira, A. H. V. 2000. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol. 47:80-86.
10. Pérez-Severiano, F., Ríos, C., and Segovia, J. 2000. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res. 862:234-237.
11. Santamaría, A., Pérez-Severiano, F., Rodrí guez-Martínez, E., Maldonado, P. D., Pedraza-Chaverri, J., Ríos, C., and Segovia, J. 2001. Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease. Neurochem. Res. 26:419-424.
12. Pérez-Severiano, F., Escalante, B., Vergara, P., Ríos, C., and Segovia, J. 2002. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res. 951:36-42.
13. Segovia, J. 2002. Transgenic model for the study of oxidative damage in Huntington's disease. Methods Enzymol. 353:365-373.
14. Ali, S. F., LeBel, C. P., and Bondy, S. C. 1992. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13:637-648.
15. Hafeman, D. G., Sunde, R. A., and Hoekstra, W. G. 1974. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104:580-587.
16. Pedraza-Chaverri, J., Granados-Silvestre, M. D., Medina-Campos, O. N., Maldonado, P. D., Olivares-Corichi, I. M., and Ibarra-Rubio, M. E. 2001. Post-transcriptional control of catalase expression in garlic-treated rats. Mol. Cell Biochem. 216:9-19.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193:265-275.
18. Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., and Beal, M. F. 2000. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J. Neurosci. 20:1-7.
19. Kish, S. J., Morito, C. L., and Hornykiewicz, O. 1986. Brain glutathione peroxidase in neurodegenerative disorders. Neurochem. Pathol. 4:23-28.
20. Cruz-Aguado, R., Francis-Turner, L., Díaz, C. M., and Antúnez, I. 2000. Quinolinic acid lesion induces changes in rat striatal glutathione metabolism. Neurochem. Int. 37:53-60.
21. Rodríguez-Martínez, E., Camacho, A., Maldonado, P. D., Pedraza-Chaverrí, J., Santamaría, D., Galvín-Arzate, S., and Santamaría, A. 2000. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res. 858:436-439.
22. Lindenau, J., Noack, H., Asayama, K., and Wolf, G. 1998. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia 24:252-256.
23. Lee, S. R., Bar-Noy, S., Kwon, J., Levine, R. L., Stadtman, T. C., and Rhee, S. G. 2000. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. USA 97:2521-2526.
24. Halliwell, B., and Gutteridge, J. M. C. 1985. Protection against oxygen radicals in biological systems: The superoxide theory of oxygen toxicity. Pages 68-138, in Halliwell, B., and Gutteridge, J. M. C. (eds.), Free Radicals in Biology and Medicine, Clarendon Press, Oxford.